Cas:6500-64-7 5-(3-Methoxyphenyl)pentanoic acid manufacturer & supplier

We serve Chemical Name:5-(3-Methoxyphenyl)pentanoic acid CAS:6500-64-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-(3-Methoxyphenyl)pentanoic acid

Chemical Name:5-(3-Methoxyphenyl)pentanoic acid
CAS.NO:6500-64-7
Synonyms:5-(3′-Methoxyphenyl)pentan-1-oic acid;5-(3-Methoxyphenyl)pentanoic acid;5-(3′-methoxyphenyl)pentanoic acid;5-<3-Methoxy-phenyl>-valeriansaeure;5-(m-methoxyphenyl)pentanoic acid;Benzenepentanoic acid, 3-methoxy-;5-(3′-methoxyphenyl)valeric acid
Molecular Formula:C12H16O3
Molecular Weight:208.254
HS Code:2918990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:371.1±25.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.521
PSA:46.53000
Exact Mass:208.109940
LogP:2.62

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-(3′-Methoxyphenyl)pentan-1-oic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(3′-methoxyphenyl)valeric acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzenepentanoic acid, 3-methoxy- Use and application,3-Methoxy-phenyl&gt technical grade,usp/ep/jp grade.


Related News: The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study. 5-(3-Methoxyphenyl)pentanoic acid manufacturer The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study. 5-(3-Methoxyphenyl)pentanoic acid supplier Standard respiratory support therapies are used to treat the symptoms and wait for the virus to be cleared by itself. 5-(3-Methoxyphenyl)pentanoic acid vendor The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth. 5-(3-Methoxyphenyl)pentanoic acid factory Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.